CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen, a division of Life Technologies Corporation (NASDAQ:LIFE), today announced that four of its scientists whose work is focused in stem cell research are editors of two recently published books that capture many of the latest findings in this field and provide comprehensive guidelines for applying technologies to advance related applications. Emerging Technology Platforms for Stem Cells, by John Wiley & Sons, and Regulatory Networks in Stem Cells, by Springer Science + Business Media are expected to be essential references for researchers, scientists and clinicians applying stem cell science to personalized and regenerative medicine.
